Llwytho...
Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients
INTRODUCTION: In clinical trials, fixed-dose enoxaparin (40 mg once daily) reduces the risk of venous thromboembolism (VTE) in medically-ill patients. However, morbidly obese patients were under-represented in these trials and using fixed-dose enoxaparin in obese patients may be inadequate. We compl...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2009
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3245965/ https://ncbi.nlm.nih.gov/pubmed/19272635 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.thromres.2009.02.003 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|